Man/woman ratio
|
>2 |
0.83 (0.69-1.00) |
0.047 |
37 |
0.12 |
Excluding DIVINe Study Group[9] |
0.83 (0.71-0.98) |
0.03 |
27 |
0.21 |
<2 |
0.96 (0.87-1.06) |
0.45 |
0 |
0.43 |
Stroke Prevention
|
Primary prevention |
0.91 (0.73-1.12) |
0.37 |
27 |
0.19 |
Excluding DIVINe Study Group[9] |
0.90 (0.74-1.09) |
0.29 |
15 |
0.31 |
Secondary prevention |
0.91 (0.82-1.02) |
0.11 |
29 |
0.21 |
Baseline homocysteine (umol/L)
|
<14 |
0.90 (0.77-1.06) |
0.22 |
38 |
0.14 |
14-20 |
1.02 (0.73-1.43) |
0.91 |
42 |
0.18 |
Excluding DIVINe Study Group[9] |
0.94 (0.82-1.07) |
0.33 |
0 |
0.51 |
>20 |
0.78 (0.58-1.05) |
0.10 |
0 |
0.46 |
Homocysteine lowering
|
> 20% |
0.89 (0.78-1.02) |
0.09 |
31 |
0.17 |
Excluding DIVINe Study Group[9] |
0.90 (0.80-1.00) |
0.052 |
18 |
0.29 |
<20% |
0.86 (0.63-1.16) |
0.33 |
37 |
0.19 |
Treatment regimens
|
Folic acid plus vitamin B12 plus vitamin B6 |
0.90 (0.81-1.01) |
0.07 |
17 |
0.27 |
Excluding DIVINe Study Group[9] |
0.91 (0.82-0.99) |
0.04 |
5 |
0.40 |
Folic acid plus vitamin B12 |
1.01 (0.86-1.20) |
0.86 |
- |
- |
Folic acid only |
0.75 (0.36-1.57) |
0.44 |
49 |
0.14 |
Folic acid (mg)
|
<1 |
0.74 (0.58-0.94) |
0.01 |
0 |
0.73 |
1-3 |
0.95 (0.83-1.09) |
0.45 |
43 |
0.08 |
Excluding DIVINe Study Group[9] |
0.94 (0.83-1.07) |
0.36 |
37 |
0.13 |
>3 |
0.95 (0.72-1.25) |
0.72 |
0 |
0.59 |
Vitamin B6 (mg)
|
>40 |
0.91 (0.73-1.12) |
0.36 |
32 |
0.21 |
40 or less |
0.90 (0.78-1.04) |
0.15 |
18 |
0.28 |
Excluding DIVINe Study Group[9] |
0.91 (0.83-1.01) |
0.09 |
0 |
0.46 |
Vitamins B12 (mg)
|
<0.5 |
0.91 (0.82-1.01) |
0.07 |
0 |
0.45 |
1 |
0.99 (0.80-1.22) |
0.90 |
53 |
0.07 |
Excluding DIVINe Study Group[9] |
0.97 (0.80-1.16) |
0.71 |
47 |
0.13 |
2 |
0.90 (0.58-1.38) |
0.62 |
- |
- |
Disease status
|
Renal disease |
0.87 (0.63-1.18) |
0.37 |
28 |
0.22 |
Excluding DIVINe Study Group[9] |
0.86 (0.67-1.10) |
0.23 |
1 |
0.41 |
Other |
0.92 (0.83-1.02) |
0.12 |
26 |
0.19 |
Duration of the follow-up period (years)
|
>3 |
0.89 (0.79-1.01) |
0.07 |
31 |
0.13 |
Excluding DIVINe Study Group[9] |
0.89 (0.80-1.00) |
0.048 |
24 |
0.20 |
<3 |
0.99 (0.82-1.21) |
0.95 |
0 |
0.47 |
Study quality
|
High |
0.92 (0.83-1.02) |
0.11 |
21 |
0.22 |
Excluding DIVINe Study Group[9] |
0.92 (0.84-1.01) |
0.08 |
11 |
0.34 |
Low |
0.80 (0.54-1.19) |
0.27 |
45 |
0.14 |